Rachel Klemovitch, Assistant Editor05.29.24
The world’s largest accelerator of medical technologies companies, MedTech Innovator (MTI) has announced its 2024 Accelerator Cohort. 65 companies were selected to participate in the four-month program. Roughly 1,300 companies applied to participate in the program.
The 2024 cohort of medical device, diagnostic, and digital health companies will have access and visibility to the world’s leading strategic manufacturers, investors, healthcare providers, payers, patients, and other industry stakeholders.
“Our accelerator has become the gold standard, thanks to our industry-leading track record of identifying and refining the most innovative medtech startups in the world. Since launching MedTech Innovator, our more than 600 graduates have received 310 FDA approvals and clearances and secured $8 billion in follow-on funding,” said Paul Grand, CEO and founder of MedTech Innovator.
In the MTI accelerator program, cohort companies will compete for the vote of the audiences at the industry’s leading conferences for $800,000 in non-dilutive funding. The program launches at the Innovator Summit 2024 from June 12-13. Cohort companies will present at an investor showcase at Wilson Sonsini’s 31st Medical Device Digital Health Conference on June 14 in San Francisco.
192 applicants were selected to advance to the 2024 MedTech Innovator Road Tour in Los Angeles, Washington D.C., and Dublin, Ireland to pitch events. These companies were able to meet and receive feedback from over 300 SMEs. Based on evaluations at the pitch events and subsequent diligence, 65 companies were selected, representing 14 U.S. states and 16 countries.
“Having evaluated thousands of applicants since November, I can tell you definitively that the 2024 MedTech Innovator Cohort represents the best-emerging startups around the globe. We are excited to spend the next four months with our industry-leading corporate partners and industry experts, to help these entrepreneurs advance their medical device, diagnostic, and digital health innovations to improve the lives of millions,” Grand added.
Five cohort companies will participate in the MTI/ASPS Plastic Surgery Accelerator track held in partnership with the American Society for Plastic Surgeons (ASPS). Another five companies will participate in the Heart and Brain Health Accelerator in collaboration with the American Heart Association’s Center for Health Technology and Innovation (CHTI), and five companies will participate in the Military Medicine track in partnership with the Medical Technology Enterprise Consortium (MTEC).
Participants in these specialty tracks will receive additional mentorship from their respective sponsors/collaborators and opportunities to participate in additional industry events.
The MedTech Innovator accelerator will culminate October 14-17 at The MedTech Conference, powered by AdvaMed, where companies will present in showcase panels and gain access to industry and investor partnering opportunities. The MedTech Innovator early-stage Finals competition will be held on October 16, and the mid-stage companies will participate in a finals competition on November 19-21 at the MedTech Strategist Innovation Summit in San Diego.
The 2024 cohort of medical device, diagnostic, and digital health companies will have access and visibility to the world’s leading strategic manufacturers, investors, healthcare providers, payers, patients, and other industry stakeholders.
“Our accelerator has become the gold standard, thanks to our industry-leading track record of identifying and refining the most innovative medtech startups in the world. Since launching MedTech Innovator, our more than 600 graduates have received 310 FDA approvals and clearances and secured $8 billion in follow-on funding,” said Paul Grand, CEO and founder of MedTech Innovator.
In the MTI accelerator program, cohort companies will compete for the vote of the audiences at the industry’s leading conferences for $800,000 in non-dilutive funding. The program launches at the Innovator Summit 2024 from June 12-13. Cohort companies will present at an investor showcase at Wilson Sonsini’s 31st Medical Device Digital Health Conference on June 14 in San Francisco.
192 applicants were selected to advance to the 2024 MedTech Innovator Road Tour in Los Angeles, Washington D.C., and Dublin, Ireland to pitch events. These companies were able to meet and receive feedback from over 300 SMEs. Based on evaluations at the pitch events and subsequent diligence, 65 companies were selected, representing 14 U.S. states and 16 countries.
This Year’s Cohort
- AccurKardia - New York City, NY
- Acorai - Helsingborg, Sweden
- Akeyna - Boston, MA
- Arsenal Medical - Waltham, MA
- Astek Diagnostics - Baltimore, MD
- ATDev - Los Angeles, CA
- Aurie - Syracuse, N.Y.
- Avance Innovations - London, England
- BrainSpace - Seattle, Wash.
- Butterfly Medical - Yokneam, Israel
- CardioSignal - Turku, Finland
- Cellular Vehicles - San Mateo, CA
- Craif - Tokyo, Japan
- CranioSense - Boston, MA
- Cyted Health - Cambridge, United Kingdom
- CytoVeris - Farmington, CT
- DiaMonTech - Berlin, Germany
- Dopl Technologies - Seattle, Wash.
- Droplet IV - Copenhagen, Denmark
- Endo-TAGSS - Shawnee, KS
- Fasciotens - Cologne, Germany
- FemTherapeutics - Montreal, Canada
- FibriCheck - New York City, NY
- Flow Medical - Chicago, IL
- HealthTech Connex - Surrey BC, Canada
- iCE Neurosystems - Washington, D.C.
- INIA Biosciences - Boston, MA
- Innova Vascular - Irvine, CA
- Invicta Medical - Santa Clara, CA
- Juniper Biomedical - Worcester, MA
- Laguna Tech USA - Irvine, CA
- LaNua Medical - Dublin, Ireland
- LATTICE MEDICAL - Loos, France
- Ligence - Kaunas, Lithuania
- myBiometry - Boston, MA
- Nanobiofab - Frederick, MD
- NANOCHON - Washington, D.C.
- NeuroBionics - Cambridge, MA
- Neuspera Medical - San Jose, CA
- Nurami Medical - Haifa, Israel
- Ortho-tag - Palm Beach Gardens, FF
- Orthomod - Dayton, OH
- Ozlo - Boston, MA
- Paxos Medical - Minneapolis, MN
- Plexaa - London, England
- Prevencio - Kirkland, Wash.
- ReConstruct Bio - Boston, MA
- Relief Cardiovascular - Costa Mesa, CA
- Remedi - Seoul, Korea
- Robeauté - Paris, France
- Salvia BioElectronics - Eindhoven, The Netherlands
- Samay - Mountain View, Calif. and Medellín, Colombia
- SanaHeal - Cambridge, MA
- SmartCardia - Lausanne, Switzerland
- Solenic Medical - Addison, TX
- Somnics Health - Redwood City, CA
- Spiorad Medical - Dublin, Ireland
- Summa Therapeutics - Cambridge, MA
- Surgical Automations - Dallas, TX
- SwiftDuct - Sakhnin, Israel
- Taurus Vascular - Houston, TX
- The Shape Sensing Company - Austin, TX
- TYBR Health - Houston, TX
- Vonova - San Diego, CA
- X-Bolt Orthopedics - Dublin, Ireland
“Having evaluated thousands of applicants since November, I can tell you definitively that the 2024 MedTech Innovator Cohort represents the best-emerging startups around the globe. We are excited to spend the next four months with our industry-leading corporate partners and industry experts, to help these entrepreneurs advance their medical device, diagnostic, and digital health innovations to improve the lives of millions,” Grand added.
Five cohort companies will participate in the MTI/ASPS Plastic Surgery Accelerator track held in partnership with the American Society for Plastic Surgeons (ASPS). Another five companies will participate in the Heart and Brain Health Accelerator in collaboration with the American Heart Association’s Center for Health Technology and Innovation (CHTI), and five companies will participate in the Military Medicine track in partnership with the Medical Technology Enterprise Consortium (MTEC).
Participants in these specialty tracks will receive additional mentorship from their respective sponsors/collaborators and opportunities to participate in additional industry events.
The MedTech Innovator accelerator will culminate October 14-17 at The MedTech Conference, powered by AdvaMed, where companies will present in showcase panels and gain access to industry and investor partnering opportunities. The MedTech Innovator early-stage Finals competition will be held on October 16, and the mid-stage companies will participate in a finals competition on November 19-21 at the MedTech Strategist Innovation Summit in San Diego.